tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Imugene Updates Market on Director Paul Hopper’s Increased Performance Rights Holding
Company AnnouncementsImugene Updates Market on Director Paul Hopper’s Increased Performance Rights Holding
2d ago
Imugene Plans New Issue of Convertible Notes and Warrants
PremiumCompany Announcements
Imugene Plans New Issue of Convertible Notes and Warrants
3d ago
Imugene Enhances Financial Flexibility with Convertible Notes and Warrants Agreement
PremiumCompany Announcements
Imugene Enhances Financial Flexibility with Convertible Notes and Warrants Agreement
3d ago
Imugene Advances Azer-cel Program with FDA Support and Strategic Partnerships
PremiumCompany Announcements
Imugene Advances Azer-cel Program with FDA Support and Strategic Partnerships
5d ago
Imugene Announces Webinar on Positive FDA Feedback for Azer-cel Program
PremiumCompany Announcements
Imugene Announces Webinar on Positive FDA Feedback for Azer-cel Program
14d ago
Imugene Receives FDA Support for Phase 3 Study of Azer-cel
PremiumCompany AnnouncementsImugene Receives FDA Support for Phase 3 Study of Azer-cel
14d ago
Imugene’s Azer-cel CAR T Therapy Shows Promising Results in Phase 1b Trial
Premium
Company Announcements
Imugene’s Azer-cel CAR T Therapy Shows Promising Results in Phase 1b Trial
20d ago
Imugene Collaborates with JW Therapeutics on Innovative Cancer Treatment
Premium
Company Announcements
Imugene Collaborates with JW Therapeutics on Innovative Cancer Treatment
25d ago
Imugene and JW Therapeutics Collaborate on Novel Cancer Therapy
PremiumCompany Announcements
Imugene and JW Therapeutics Collaborate on Novel Cancer Therapy
25d ago
Imugene AGM Results: Shareholder Dissent and Board Support
PremiumCompany Announcements
Imugene AGM Results: Shareholder Dissent and Board Support
1M ago
Imugene Issues Disclaimer for Annual General Meeting Presentation
PremiumCompany Announcements
Imugene Issues Disclaimer for Annual General Meeting Presentation
1M ago
Imugene Announces Webinar on CAR T Naïve Lymphomas and ASH Presentation
PremiumCompany Announcements
Imugene Announces Webinar on CAR T Naïve Lymphomas and ASH Presentation
2M ago
Imugene’s Azer-cel Selected for Prestigious ASH Presentation
PremiumCompany AnnouncementsImugene’s Azer-cel Selected for Prestigious ASH Presentation
2M ago
Imugene Issues Shares to Precision Biosciences, Marking Milestone Achievement
Premium
Company Announcements
Imugene Issues Shares to Precision Biosciences, Marking Milestone Achievement
2M ago
Imugene Issues Shares to Precision Biosciences Following Milestone Achievement
Premium
Company Announcements
Imugene Issues Shares to Precision Biosciences Following Milestone Achievement
2M ago
Imugene Achieves 81% Response Rate in CAR T-cell Therapy Trial
PremiumCompany Announcements
Imugene Achieves 81% Response Rate in CAR T-cell Therapy Trial
2M ago
Imugene Reports Promising Results in CAR T-Naïve Lymphoma Trial
PremiumCompany Announcements
Imugene Reports Promising Results in CAR T-Naïve Lymphoma Trial
2M ago
Imugene’s PD1-Vaxx Colorectal Cancer Trial to Feature at ESMO 2025
PremiumCompany Announcements
Imugene’s PD1-Vaxx Colorectal Cancer Trial to Feature at ESMO 2025
2M ago
Imugene Expands Market Presence with New Securities Quotation
PremiumCompany Announcements
Imugene Expands Market Presence with New Securities Quotation
2M ago
Imugene Announces 2025 Annual General Meeting and Remuneration Enhancements
PremiumCompany AnnouncementsImugene Announces 2025 Annual General Meeting and Remuneration Enhancements
2M ago
Imugene’s Azer-cel CAR T Therapy Shows Promising Results in Phase 1b Trial
Premium
Company Announcements
Imugene’s Azer-cel CAR T Therapy Shows Promising Results in Phase 1b Trial
3M ago
Imugene Issues Over 5.5 Million Quoted Options to SPP Participants
Premium
Company Announcements
Imugene Issues Over 5.5 Million Quoted Options to SPP Participants
4M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >